Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Case Report


Article page

200- 203


Authors Details

Tushar Kant Singh, Rakesh Sharma, Ziaul Haq Yasir*, Mukesh Kumar


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 526

PDF Downloaded: 216


MOGAD: A novel disease


Case Report

Author Details : Tushar Kant Singh, Rakesh Sharma, Ziaul Haq Yasir*, Mukesh Kumar

Volume : 10, Issue : 1, Year : 2024

Article Page : 200-203

https://doi.org/10.18231/j.ijceo.2024.036



Suggest article by email

Get Permission

Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an immune-mediated inflammatory neurological disease and a new addition to the demyelinating disorders of the central nervous system(CNS).In MOGAD, specific antibodies (MOG IgG) targeting MOG protein lead to primary demyelination in the CNS, but notably spare astrocytes. The most frequent presentation in children is ADEM and in adult ON. We present a case of 20 year old female who visited our OPD with complaints of diminution of vision with muscular weakness and strain while walking with a history of two similar episodes in the past. The clinical characteristics, laboratory investigation and neuroimaging help in diagnosis. Although the prognosis is generally favorable but severe residual disability can also occur.This underscores the importance of identifying the causes of demyelination on time and prompt treatment of this rather novel disease by judicious use of steroids based on standard protocolresulting in the general well-being of the patient. The present case therefore highlights the need to create awareness of the Clinical-Lab-Imaging characteristics of MOGAD andalso suggests the importance of making a detailed multidisciplinary approach into the cause of optic neuritis for better prognosis.
 

Keywords: MOGAD disease, Optic neuritis, Demyelinating disease, Optic atrophy, Multiple sclerosis.


How to cite : Singh T K, Sharma R, Yasir Z H, Kumar M, MOGAD: A novel disease. Indian J Clin Exp Ophthalmol 2024;10(1):200-203

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.